Heparin-bonded cardiopulmonary bypass circuits reduce cognitive dysfunction

J Cardiothorac Vasc Anesth. 2002 Feb;16(1):37-42. doi: 10.1053/jcan.2002.29659.

Abstract

Objective: To determine the incidence of cerebral dysfunction in cardiac surgical patients exposed to heparin-bonded cardiopulmonary bypass (HB-CPB) versus nonheparin-bonded cardiopulmonary bypass (NH-CPB) circuits through neuropsychometric testing and to correlate these findings with markers of the systemic inflammatory response to CPB.

Design: Prospective, randomized, blinded clinical trial.

Setting: University hospital.

Participants: Sixty-one patients undergoing elective cardiac surgery.

Interventions: A cohort of 61 patients scheduled for elective coronary artery bypass graft surgery were prospectively randomized to receive either HB-CPB or NH-CPB circuits during surgery. Patients were evaluated for cerebral injury using a battery of neuropsychometric tests at the following 3 time points: (1) before surgery as a baseline examination, (2) postoperative day 5, and (3) postoperative week 6. Blood samples were drawn to measure inflammatory markers at the following time points: (1) preincision, after induction of anesthesia, (2) 15 minutes after onset of CPB, (3) 30 minutes after CPB, (4) 6 hours postoperatively, and (5) 24 hours postoperatively.

Measurements and main results: Neuropsychometric performance was evaluated by group-rate and event-rate analyses. By group-rate analysis, patients undergoing surgery with HB-CPB performed significantly better at 5 days after surgery on 2 neuropsychometric tests (trails A [p < 0.01] and finger tapping with the dominant hand [p < 0.01]) and at 6 weeks after surgery on one neuropsychometric test (trails A [p < 0.01]). By event-rate analysis, at 5 days, patients undergoing surgery with HB-CPB circuits had less cognitive dysfunction (p < 0.05) compared with patients undergoing surgery with NH-CPB circuits. Serum samples were analyzed to evaluate markers of complement activation (C3a), proinflammatory cytokines (tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6), and coagulation (thrombin-antithrombin complex [TAT]) using the quantitative sandwich enzyme immunoassay technique. Although there were no significant differences in cytokine activation in either group, C3a was significantly higher in the NH-CPB group intraoperatively at 1 hour after CPB (p < 0.05), and TAT was higher in the HB-CPB group at 24 hours after surgery (p < 0.05).

Conclusions: Patients undergoing cardiac surgery with CPB have less postoperative cognitive dysfunction during CPB when HB-CPB circuits are employed. Although there was a relationship, this finding did not correlate with decreased complement activation intraoperatively and activation of coagulation postoperatively.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antithrombin III / analysis
  • Biomarkers / analysis
  • Cardiopulmonary Bypass* / adverse effects
  • Cardiopulmonary Bypass* / instrumentation
  • Coated Materials, Biocompatible*
  • Cognition Disorders / diagnosis
  • Cognition Disorders / etiology*
  • Cognition Disorders / prevention & control
  • Coronary Artery Bypass
  • Double-Blind Method
  • Female
  • Heparin*
  • Humans
  • Inflammation Mediators / blood
  • Male
  • Middle Aged
  • Neuropsychological Tests
  • Peptide Hydrolases / analysis
  • Prospective Studies
  • Systemic Inflammatory Response Syndrome / diagnosis
  • Systemic Inflammatory Response Syndrome / etiology

Substances

  • Biomarkers
  • Coated Materials, Biocompatible
  • Inflammation Mediators
  • antithrombin III-protease complex
  • Antithrombin III
  • Heparin
  • Peptide Hydrolases